B.K.Arogyam & Research Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 12840.64%
(FY 2023)
- Profit 14779.79%
(FY 2023)
- Ebitda 19907.00%
(FY 2023)
- Net Worth 13519.33%
(FY 2023)
- Total Assets 8158.53%
(FY 2023)
About B.K.Arogyam & Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Janaki Chaurasiya, Shashi Chaurasiya, and Shimali Chaurasiya serve as directors at the Company.
- CIN/LLPIN
U74999UP2017PTC089530
- Company No.
089530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does B.K.Arogyam & Research Private Limited offer?
B.K.Arogyam & Research Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine.
Who are the key members and board of directors at B.K.Arogyam & Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Janaki Chaurasiya  | Director | 31-May-2018 | Current |
| Shashi Chaurasiya | Director | 31-May-2018 | Current |
| Shimali Chaurasiya | Additional Director | 06-Sep-2019 | Current |
Financial Performance of B.K.Arogyam & Research.
B.K.Arogyam & Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12840.64% increase. The company also saw a substantial improvement in profitability, with a 14779.79% increase in profit. The company's net worth Soared by an impressive increase of 13519.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B.K.Arogyam & Research?
Unlock access to B.K.Arogyam & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
B.K. Arogyam Healthcare Private LimitedActive 4 years 1 monthJanaki Chaurasiya and Shimali Chaurasiya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at B.K.Arogyam & Research?
Unlock and access historical data on people associated with B.K.Arogyam & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B.K.Arogyam & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B.K.Arogyam & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
